相关实验视频

Updated: Jan 12, 2026

The Soft Agar Colony Formation Assay

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

通过调节miR-625/LOXL4/Wnt/β-catenin通路,LNC511可以抑制肺癌的进展

Daifang Chu¹, Hua Zong², Yangyang Duan¹

¹Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, Air Force Medical University, Xi'an 710038, China.

Cellular signalling

|November 7, 2025

概括

这项研究表明,长非编码RNA LNC511抑制了肺癌 (LC) 的进展. LNC511通过调节miR-625,LOXL4和Wnt/β-catenin通路来抑制LC细胞的增殖和干细胞.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
遗传学是一个遗传学.

背景情况:

肺癌 (LC) 是全球癌症死亡的主要原因.
长非编码RNAs (lncRNAs) 与癌症的发展和进展有关.

研究的目的:

为了研究 lncRNA LNC511 在肺癌中的作用.
阐明LNC511在LC细胞中的功能背后的分子机制.

主要方法:

微阵列分析以识别差异表达的 lncRNAs.
逆转录定量聚合酶连锁反应 (RT-qPCR) 用于表达分析.
功能性测试 (繁殖,活力,迁移,入侵,亡,茎状) 来评估LNC511的影响.
涉及RNA-RNA相互作用和信号通路分析的分子机制研究.

主要成果:

在LC组织和细胞系中,LNC511显著下调.
过度表达LNC511抑制了LC细胞的增殖,活力,迁移,入侵和干细胞.
作为miR-625的分子海绵,LNC511可以调节LOXL4并禁用Wnt/β-catenin通路.
通过操纵miR-625,LOXL4或Wnt/β-catenin通路来逆转LNC511的影响.

结论:

在肺癌中,LNC511作为瘤抑制剂起作用.
通过miR-625/LOXL4/Wnt/β-catenin轴,LNC511可以抑制LC细胞的增殖和干细胞.
LNC511代表了肺癌治疗的潜在治疗标.

关键词:

在LOXL4L4中使用.长非编码RNA LNC51111 长非编码RNA LNC51111 长非编码RNA 肺癌是一种肺癌.一个的茎.在Wnt/β-catenin信号通路中.微型RNA-625-3p是什么意思

更多相关视频

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Canonical Wnt Signaling Pathway

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...

Non-Canonical Wnt Signaling Pathways

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...